• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本和美国溃疡性结肠炎患病率和发病率的变化趋势。

Trends in the prevalence and incidence of ulcerative colitis in Japan and the US.

机构信息

Global Epidemiology, Office of the Chief Medical Officer, Janssen Research and Development, LLC, Titusville, NJ, USA.

出版信息

Int J Colorectal Dis. 2023 May 19;38(1):135. doi: 10.1007/s00384-023-04417-6.

DOI:10.1007/s00384-023-04417-6
PMID:37204516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10198866/
Abstract

PURPOSE

To estimate and compare annual prevalence and incidence, and demographic characteristics of patients with ulcerative colitis (UC) in Japan and the United States (US).

METHODS

All patients with UC were identified from large employment-based healthcare claims databases (Japan Medical Data Center [JMDC] in Japan and IBM MarketScan Commercial Claims and Encounters database [CCAE] in the US), from 2010 to 2019. Cases were confirmed using International Classification of Disease-9/10 codes with/without Anatomical Therapeutic Chemical codes. Annual age-standardized prevalence and incidence rates were estimated for the JMDC by direct standardization using the CCAE as the standard population.

RESULTS

Patients with UC were younger in Japan than in the US and men were affected more than women, whereas the reverse was true in the US. Annual prevalence per 100,000 population increased significantly from 5 in 2010 to 98 in 2019 in Japan and from 158 to 233 in the US. Prevalence increased in men more than in women and in all age groups in Japan, whereas increases were observed similarly in men and women, and in the 6 to < 65-year age groups in the US. Annual incidence per 100,000 person-years increased significantly over time in both sexes and in all age groups in Japan, with higher increases in women and in ≥ 18 year-olds. UC incidence rates did not change over time in the US.

CONCLUSION

Ten-year trends in epidemiology of UC differ between Japan and the US. The data point to a growing disease burden in both countries that warrants investigation of measures for prevention and treatment.

摘要

目的

估算并比较日本和美国溃疡性结肠炎(UC)患者的年患病率和发病率,以及人口统计学特征。

方法

从大型就业型医疗保健索赔数据库(日本医疗数据中心[JMDC]和美国 IBM MarketScan 商业索赔和遭遇数据库[CCAE])中确定所有 UC 患者。使用国际疾病分类第 9 版/第 10 版(ICD-9/10)代码和/或解剖治疗化学分类代码来确认病例。通过使用 CCAE 作为标准人群对 JMDC 进行直接标准化,估算了 2010 年至 2019 年期间的年龄标准化年患病率和发病率。

结果

与美国相比,日本的 UC 患者更年轻,男性多于女性,而美国则相反。日本每 10 万人的年患病率从 2010 年的 5 人增加到 2019 年的 98 人,美国从 158 人增加到 233 人。日本男性和所有年龄组的患病率均显著增加,而女性和 6 岁至<65 岁年龄组的患病率也有所增加。日本两性和所有年龄组的年发病率均呈显著上升趋势,女性和≥18 岁人群的增长率更高。美国 UC 的发病率在这十年间没有变化。

结论

日本和美国 UC 的十年流行病学趋势存在差异。这些数据表明,两国的疾病负担都在增加,需要调查预防和治疗措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/b4812007bb12/384_2023_4417_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/f2d983876e15/384_2023_4417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/6c719bd7754a/384_2023_4417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/52be3a605dee/384_2023_4417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/27bd9fed53b8/384_2023_4417_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/b4812007bb12/384_2023_4417_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/f2d983876e15/384_2023_4417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/6c719bd7754a/384_2023_4417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/52be3a605dee/384_2023_4417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/27bd9fed53b8/384_2023_4417_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8c0/10198866/b4812007bb12/384_2023_4417_Fig5_HTML.jpg

相似文献

1
Trends in the prevalence and incidence of ulcerative colitis in Japan and the US.日本和美国溃疡性结肠炎患病率和发病率的变化趋势。
Int J Colorectal Dis. 2023 May 19;38(1):135. doi: 10.1007/s00384-023-04417-6.
2
Trends in the prevalence and incidence of Crohn's disease in Japan and the United States.日本和美国克罗恩病的患病率及发病率趋势。
Int J Colorectal Dis. 2024 Apr 27;39(1):61. doi: 10.1007/s00384-024-04636-5.
3
Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey.2014 年日本溃疡性结肠炎和克罗恩病的预估患病率:一项全国性调查分析。
J Gastroenterol. 2019 Dec;54(12):1070-1077. doi: 10.1007/s00535-019-01603-8. Epub 2019 Jul 15.
4
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.1970年至2010年明尼苏达州奥尔姆斯特德县克罗恩病和溃疡性结肠炎的发病率及患病率
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863. doi: 10.1016/j.cgh.2016.10.039. Epub 2016 Nov 14.
5
Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis.日本溃疡性结肠炎患者的真实世界处方模式和医疗保健费用:一项回顾性理赔数据分析。
Adv Ther. 2021 May;38(5):2229-2247. doi: 10.1007/s12325-020-01615-4. Epub 2021 Jan 30.
6
Validation of a claims-based algorithm to identify cases of ulcerative colitis in Japan.基于索赔的算法验证用于识别日本溃疡性结肠炎病例。
J Gastroenterol Hepatol. 2022 Mar;37(3):499-506. doi: 10.1111/jgh.15732. Epub 2021 Nov 26.
7
Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan.日本溃疡性结肠炎的流行病学研究:发病率及家族聚集性。日本炎症性肠病研究委员会流行病学小组。
J Gastroenterol. 1995 Nov;30 Suppl 8:5-8.
8
Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements.以色列溃疡性结肠炎的流行病学:对以色列基布兹定居点的一项调查。
Am J Gastroenterol. 2000 Mar;95(3):693-8. doi: 10.1111/j.1572-0241.2000.01849.x.
9
The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study.美国退伍军人中炎症性肠病的发病率和流行率:一项全国队列研究。
Inflamm Bowel Dis. 2013 Apr;19(5):1059-64. doi: 10.1097/MIB.0b013e31828028ca.
10
Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina between 1995 and 2006: epidemiological and clinical characteristics.1995 年至 2006 年波斯尼亚和黑塞哥维那图兹拉地区溃疡性结肠炎:流行病学和临床特征。
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):346-53. doi: 10.1097/MEG.0b013e32832bfe05.

引用本文的文献

1
Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies.溃疡性结肠炎:发病机制、生物标志物及治疗策略的进展
Pharmgenomics Pers Med. 2025 Sep 5;18:219-238. doi: 10.2147/PGPM.S536459. eCollection 2025.
2
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn's disease in Japan in 2023.2023年日本溃疡性结肠炎和克罗恩病患者人数及患病率的全国性估计。
J Gastroenterol. 2025 Sep 2. doi: 10.1007/s00535-025-02295-z.
3
Potential miRNAs as Diagnostic Biomarkers for Differentiating Disease States in Ulcerative Colitis: A Systematic Review.

本文引用的文献

1
A Review of Research Studies Using Data from the Administrative Claims Databases in Japan.一项利用日本行政索赔数据库数据的研究综述
Drugs Real World Outcomes. 2022 Dec;9(4):543-550. doi: 10.1007/s40801-022-00331-5. Epub 2022 Sep 15.
2
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?亚洲炎症性肠病流行病学的最新情况:我们目前处于什么阶段?
Intest Res. 2022 Apr;20(2):159-164. doi: 10.5217/ir.2021.00115. Epub 2022 Apr 29.
3
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
作为溃疡性结肠炎疾病状态鉴别诊断生物标志物的潜在微小RNA:一项系统评价
Int J Mol Sci. 2025 Jul 16;26(14):6822. doi: 10.3390/ijms26146822.
4
Enhancing the Adhesion/Colonization Efficacy of Probiotics by Polysaccharide Surface Decoration for Remission from Ulcerative Colitis.通过多糖表面修饰提高益生菌的黏附/定殖功效以缓解溃疡性结肠炎
Probiotics Antimicrob Proteins. 2025 Jul 11. doi: 10.1007/s12602-025-10653-9.
5
Guselkumab in East Asians With Moderate-to-Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies.古塞库单抗治疗东亚中重度溃疡性结肠炎:QUASAR诱导和维持研究的亚组分析
J Gastroenterol Hepatol. 2025 Sep;40(9):2197-2208. doi: 10.1111/jgh.17036. Epub 2025 Jun 26.
6
Serological Assessment of Hepatitis in Patients with Inflammatory Bowel Disease in Taiwan: A Retrospective Cohort Analysis.台湾炎症性肠病患者肝炎的血清学评估:一项回顾性队列分析
Life (Basel). 2025 May 31;15(6):893. doi: 10.3390/life15060893.
7
Current and forecasted 10-year prevalence and incidence of inflammatory bowel disease in Hong Kong, Japan, and the United States.香港、日本和美国炎症性肠病的当前及预测的10年患病率和发病率。
World J Gastroenterol. 2025 May 14;31(18):105472. doi: 10.3748/wjg.v31.i18.105472.
8
Incidence and Prevalence of Chronic Spontaneous Urticaria Among Adult and Pediatric Populations in the United States.美国成人和儿童人群中慢性自发性荨麻疹的发病率和患病率
Adv Ther. 2025 Jun;42(6):2808-2820. doi: 10.1007/s12325-025-03172-0. Epub 2025 Apr 16.
9
Treatment Patterns and Economic Burden of Ulcerative Colitis in Japan: A Retrospective Claims Analysis.日本溃疡性结肠炎的治疗模式与经济负担:一项回顾性索赔分析。
Adv Ther. 2025 Mar;42(3):1435-1447. doi: 10.1007/s12325-024-03096-1. Epub 2025 Jan 24.
10
Future of Acute Severe Ulcerative Colitis-A Narrative Review.急性重症溃疡性结肠炎的未来——一篇叙述性综述
J Clin Med. 2024 Dec 18;13(24):7723. doi: 10.3390/jcm13247723.
2020 年炎症性肠病循证临床实践指南。
J Gastroenterol. 2021 Jun;56(6):489-526. doi: 10.1007/s00535-021-01784-1. Epub 2021 Apr 22.
4
Data resource profile: JMDC claims databases sourced from Medical Institutions.数据资源概况:源自医疗机构的日本医疗数据中心(JMDC)理赔数据库。
J Gen Fam Med. 2020 Aug 30;21(6):211-218. doi: 10.1002/jgf2.367. eCollection 2020 Nov.
5
The four epidemiological stages in the global evolution of inflammatory bowel disease.炎症性肠病全球演变的四个流行病学阶段。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):56-66. doi: 10.1038/s41575-020-00360-x. Epub 2020 Oct 8.
6
Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.美国2007 - 2016年大型国家数据库中儿童和成人炎症性肠病的患病率:近期估计
Inflamm Bowel Dis. 2020 Mar 4;26(4):619-625. doi: 10.1093/ibd/izz182.
7
Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey.2014 年日本溃疡性结肠炎和克罗恩病的预估患病率:一项全国性调查分析。
J Gastroenterol. 2019 Dec;54(12):1070-1077. doi: 10.1007/s00535-019-01603-8. Epub 2019 Jul 15.
8
Evidence-based clinical practice guidelines for inflammatory bowel disease.炎症性肠病的循证临床实践指南。
J Gastroenterol. 2018 Mar;53(3):305-353. doi: 10.1007/s00535-018-1439-1. Epub 2018 Feb 10.
9
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
10
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.